ArticleMediterranean journal of rheumatology2022
Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders.
Arif Alkan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it